实用药物与临床
實用藥物與臨床
실용약물여림상
PRACTICAL PHARMACY AND CLINICAL REMEDIES
2014年
5期
547-549
,共3页
哮喘%沙美特罗替卡松%炎症介质
哮喘%沙美特囉替卡鬆%炎癥介質
효천%사미특라체잡송%염증개질
Asthma%Salmeterol fluticasone%Mediators of inflammation
目的:探讨沙美特罗替卡松吸入对哮喘患者血清炎症介质水平的影响。方法选择80例哮喘急性发作期患者,随机分为观察组和对照组。两组患者均予以抗感染、止咳祛痰和解痉平喘等对症治疗。观察组加用沙美特罗替卡松吸入,1吸/次,2次/d;对照组予以口服茶碱缓释片,0.1 g/次,2次/d,两组均连用8周。观察两组患者治疗前和治疗后血清白细胞介素( IL)-4、8、9和10水平的变化,并进行疗效及安全性评价。结果治疗8周后,两组患者血清IL-4、8和9水平均明显下降,血清IL-10水平均明显上升(P<0.05或P<0.01),且观察组下降或上升值较对照组更明显(P <0.05);同时观察组的临床总有效率明显高于对照组(χ2=4.11,P <0.05);两组治疗期间不良反应较轻,无严重的药物不良反应。结论沙美特罗替卡松吸入治疗哮喘疗效肯定,安全性较好,作用与其能降低血清IL-4、8和9水平,提高血清IL-10水平,抑制气道炎症反应密切相关。
目的:探討沙美特囉替卡鬆吸入對哮喘患者血清炎癥介質水平的影響。方法選擇80例哮喘急性髮作期患者,隨機分為觀察組和對照組。兩組患者均予以抗感染、止咳祛痰和解痙平喘等對癥治療。觀察組加用沙美特囉替卡鬆吸入,1吸/次,2次/d;對照組予以口服茶堿緩釋片,0.1 g/次,2次/d,兩組均連用8週。觀察兩組患者治療前和治療後血清白細胞介素( IL)-4、8、9和10水平的變化,併進行療效及安全性評價。結果治療8週後,兩組患者血清IL-4、8和9水平均明顯下降,血清IL-10水平均明顯上升(P<0.05或P<0.01),且觀察組下降或上升值較對照組更明顯(P <0.05);同時觀察組的臨床總有效率明顯高于對照組(χ2=4.11,P <0.05);兩組治療期間不良反應較輕,無嚴重的藥物不良反應。結論沙美特囉替卡鬆吸入治療哮喘療效肯定,安全性較好,作用與其能降低血清IL-4、8和9水平,提高血清IL-10水平,抑製氣道炎癥反應密切相關。
목적:탐토사미특라체잡송흡입대효천환자혈청염증개질수평적영향。방법선택80례효천급성발작기환자,수궤분위관찰조화대조조。량조환자균여이항감염、지해거담화해경평천등대증치료。관찰조가용사미특라체잡송흡입,1흡/차,2차/d;대조조여이구복다감완석편,0.1 g/차,2차/d,량조균련용8주。관찰량조환자치료전화치료후혈청백세포개소( IL)-4、8、9화10수평적변화,병진행료효급안전성평개。결과치료8주후,량조환자혈청IL-4、8화9수평균명현하강,혈청IL-10수평균명현상승(P<0.05혹P<0.01),차관찰조하강혹상승치교대조조경명현(P <0.05);동시관찰조적림상총유효솔명현고우대조조(χ2=4.11,P <0.05);량조치료기간불량반응교경,무엄중적약물불량반응。결론사미특라체잡송흡입치료효천료효긍정,안전성교호,작용여기능강저혈청IL-4、8화9수평,제고혈청IL-10수평,억제기도염증반응밀절상관。
Objective To discuss the influence of salmeterol fluticasone inhalation on serum inflammatory me-diators of asthma patients. Methods 80 cases of asthma patients in acute stage of attack were randomly divided into observation group and control group. The patients in the two groups were given anti-infection,resolving phlegm and re-lieving cough,relieving spasmolysis and asthma,etc treatment. The patients in observation group were given salmeterol fluticasone inhalation one suction per time,two times daily for 8 weeks;while the patients in control group were given theophylline sustained release tablets 0. 1 g,one time,two times daily for 8 weeks. The changes of serum interleukin-4, 8,9 and 10 (IL-4,8,9 and 10) levels were observed before and after medical treatment,and the effect and security were carried on as well. Results After 8 weeks′ medical treatment,the serum IL-4,8 and 9 levels of patients in the two groups declined obviously,while the serum IL-10 level rose obviously (P<0. 05 or P<0. 01),and the declining or rising rate in observation group was much higher than that in control group (P<0. 05). The total clinical efficiency in observation group was much higher than that in control group (χ2 =4. 11,P<0. 05). During the medical treatment, there were no serious drug adverse reactions ( ADR) . Conclusion The inhalation of salmeterol fluticasone has reliable effect on patients with asthma,its mechanism is related to lowering IL-4,8 and 9 levels,improving IL-10 level,and in-hibiting the airway inflammation.